# TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults

> **NCT00315549** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 233 (actual)

## Conditions studied

- Tonsillitis
- Pharyngitis

## Interventions

- **DRUG:** Telithromycin
- **DRUG:** Penicillin

## Key facts

- **NCT ID:** NCT00315549
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 233 (ACTUAL)
- **Why stopped:** Pediatric development program terminated by sponsor
- **Last updated:** 2009-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315549, "TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00315549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*